Original ResearchFirst-in-human phase I study of oral S49076, a unique MET/AXL/FGFR inhibitor, in advanced solid tumours
Keywords: Phase I clinical trial; Tyrosine kinase inhibitor; MET inhibitor; AXL inhibitor; FGFR inhibitor; S49076; Primary cancer; Metastasis;